UK oncologist warns of cancers rapidly developing post-Covid vaccination – “I am experienced enough to know that these are not coincidental”
Dr. Angus Dalgleish, a renowned oncologist practising in the UK, recently wrote an open letter to the editor-in-chief of the medical journal The BMJ, urging the journal to “make valid informed consent for Covid vaccination a priority topic” because cancers and other diseases are rapidly progressing among “boosted” people.
Dr. Dalgleish is a Professor of Oncology at St George’s, University of London. His letter to Dr. Kamran Abbasi, the Editor in Chief of the BMJ, was written in support of a colleague’s plea to Dr. Abbasi that the BMJ make valid informed consent for Covid vaccination a priority topic.
Covid no longer needs a vaccine programme given the average age of death of Covid in the UK is 82 and from all other causes is 81 and falling.
The link with clots, myocarditis, heart attacks and strokes is now well accepted, as is the link with myelitis and neuropathy. (We predicted these side effects in our June 2020 QRBD article Sorensen et al. 2020, as the blast analysis revealed 79% homologies to human epitopes, especially PF4 and myelin.)
However, there is now another reason to halt all vaccine programmes. As a practising oncologist I am seeing people with stable disease rapidly progress after being forced to have a booster, usually so they can travel.
Even within my own personal contacts I am seeing B cell-based disease after the boosters. They describe being distinctly unwell a few days to weeks after the booster – one developing leukaemia, two work colleagues Non-Hodgkin’s lymphoma, and an old friend who has felt like he has had Long Covid since receiving his booster and who, after getting severe bone pain, has been diagnosed as having multiple metastases from a rare B cell disorder.
I am experienced enough to know that these are not the coincidental anecdotes that many suggest, especially as the same pattern is being seen in Germany, Australia and the USA.
The reports of innate immune suppression after mRNA for several weeks would fit, as all these patients to date have melanoma or B cell based cancers, which are very susceptible to immune control – and that is before the reports of suppressor gene suppression by mRNA in laboratory experiments.
This must be aired and debated immediately.
Angus Dalgleish MD FRACP FRCP FRCPath FMedSci
B Cell-Mediated Disease
In his letter, Prof. Dalgleish refers to B cell-based diseases and cancers. According to the British Society for Immunology, B cells play an important role in regulating the immune response and dysregulation of B-cell function can lead to severe consequences for the host. Such as: